Vanessa Escobar-Barboza

Endocrinology in Jersey City, New Jersey

Practice Details

Address
377 Jersey Ave Ste 220
Jersey City, NJ 07302
Geocoded location: 40.7159, -74.0494
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
MD
NPPES Enumeration
Listed with NPPES since 2007
Sole Proprietor
No
Provider Gender (NPPES)
Female
NPPES Record Updated
July 2024

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Internal Medicine, Obesity Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 10 Endocrinology, Diabetes & Metabolism practices in Jersey City carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Vanessa Escobar-Barboza's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 201-915-2380.

GLP-1 access in Jersey City, New Jersey

Adult obesity rate
28.7%
#42 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$224/mo
Typical New Jersey telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Jersey Medicaid, obesity indication

About 28.7% of New Jersey adults have obesity (BMI 30+), ranking the state #42 of 50 (CDC BRFSS). Our directory currently lists 20 GLP-1-relevant clinics in Jersey City. If a cash-pay route makes more sense, compounded semaglutide through New Jersey telehealth averages about $224/mo — well below brand-name Wegovy or Zepbound.

Explore more New Jersey options on the best New Jersey GLP-1 providers page, browse every Jersey City listing in the Jersey City clinic directory, or read the New Jersey Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Jersey City

Other Jersey City listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Jersey addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Jersey telehealth partners:

Featured Partners · Jersey City

Featured GLP-1 providers serving Jersey City

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Jersey City options on the Jersey City clinic directory, our Jersey City GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Jersey City obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Vanessa Escobar-Barboza's specialty taxonomy but not the specific medications it prescribes or its current service menu. Vanessa Escobar-Barboza is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 201-915-2380 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Vanessa Escobar-Barboza's primary specialty on file is Endocrinology.
Vanessa Escobar-Barboza is located at 377 Jersey Ave Ste 220, Jersey City, NJ 07302. The phone number listed in the registry is 201-915-2380. Its full record is public in the CMS National Provider registry under NPI 1558580936.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Vanessa Escobar-Barboza is currently accepting new patients. Call the practice at 201-915-2380 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.